Empowering Startups To Scale Globally Through Real-World Validation
Q2Scale is a tailor-made startup scaling programme, giving European top technologies in the automotive, energy, supply chain, and sustainability sectors the opportunity to receive a full package for international market penetration and beta testing in a 2-month hybrid programme.
Q2Scale effectively enhances a startup’s ability to penetrate and scale into new global markets, by leveraging its network of partners and international experts.
An initiative of the European Institute of Innovation and Technology (EIT), EIT Global Outreach links the EIT’s innovation ecosystem with those of innovation valleys worldwide, forging synergies with global innovation leaders, and creating significant value for the European economy alongside the local ecosystems.
EIT Global Outreach is currently comprised of innovation hubs in Silicon Valley, the UK, and Israel, as well as an additional platform dedicated to expanding EIT’s reach to new locations.
Q Europe connects leading corporations and startups to unlock endless innovation and growth opportunities across Europe.
It serves to empower technology in Europe, specializing in Automotive, Energy, Supply Chain, and Sustainability.
Q-Europe’s main goal is to facilitate business collaborations and commercialisation between startups and leading industry players.
A European distributor of passenger cars, light commercial vehicles and spare parts, as well as an operator of retail sites for the sale and service of vehicles.
Grand Automotive provides mobility services, automotive financing options, automotive insurance, used car sales through its regional used car company, and an array of additional services.
Get the opportunity to validate your technology in an industry setting to attract interest and fast-track entry into global markets.
Equip yourself with the tools and expertise needed to efficiently conduct PoCs with corporations. Ensure a fast-track approach by bypassing red tape and iterating quickly to meet industry needs.
Forge connections with global industry leaders, unlocking collaboration opportunities. Open doors to potential partnerships and collaborations by networking with global influential industry figures.
Connect with experienced global mentors and technological experts who provide tailored guidance to navigate the complexities of innovation around the world.
Encounter ongoing opportunities for collaboration and connection, ensuring lasting relationships beyond the programme's conclusion.
Gain targeted insights from leading international players into pressing trends in the global market.
*This timeline is tentative and subject to changes
TENTATIVE: 14-15 October, in-person session.
IF YOU DO, THIS IS YOUR Q TO SCALE.
Our exclusive bootcamp is fully funded, subject to full participation in the sessions and Demo Day.
A startup registered for bootcamp should have the capacity to select the relevant founder/co-founder to participate in full throughout the duration of the programme. We will meet every week for a two-hour session. In addition, a weekly 1:1, 60-minute personal session will be scheduled to build an accurate strategic plan tailored to the company’s global process.
The programme has a wide array of mentors and experts available to support participating startups based on your needs.
The process will be structured as follows:
Phase #1: Fill out the online application form.
*A team of experts and partners will review your application on a rolling basis, which means that the earlier you apply, the earlier we can review your submission and invite you for an online meeting to discuss further.
Phase #2: Eligible applicants will be invited to a short online qualification interview (up to 45 minutes). Please note that you might be asked for a second interview if needed.
Phase #3: The scoring committee will choose eligible Bootcamp startups as described below.
Assessment will be made by the programme partners comprised of the EIT Global Outreach team and Q-Europe domain experts.
The following elements will be taken into consideration in the assessment process:
(a) Excellence, differentiation of the technology, and product maturity for real world validation (30 pts.)
(b) Market and Impact (30 pts.)
(c) Quality and efficiency of the implementation (20 pts.)
(d) Motivation and Bootcamp fit (20 pts.)
(e) EU or Horizon Europe dimension (must)
A total score of 100 pts.
The startups with the highest cummulative scores will be selected for the Bootcamp.
Receive the Global Outreach news and latest opportunities right to your inbox
Connect & Experience offers more than training. The C&E community network is an active EU online and offline community offering easy access to opportunities, curated content, matchmaking, soft landing services, and support. The community provides a space for community builders from Europe and Horizon Europe associated countries to interact, share best practices, and collaborate to enhance your startup community.
The Health not The Death is a fundamental human right. A healthy population is not to be seen as human and social capital, an input, or by-product, towards economic growth. Alongside a healthy and sustainable environment, a solidarity, a healthy population must be the ultimate goal especially nowadays in helping Ukrainian migrants with cancer and their families.
Solidarity in health is a cornerstone of EU health policy. There are wide disparities in many health outcomes across the region and those outcomes. The access rules dramatically affect healthcare systems which are at the forefront of the migrant way, the people who are searching for help and the way how we could enhance and support their healthier and wellbeing status.
In order to ensure their access to care and continued cure in need, the probability of receiving a timely diagnosis and of surviving differs greatly from country to country where they are now. There is lack of information, help and inequalities in access. People need help in navigating cancer knowledge, diagnostics, secondary monitoring and prevention, way of treatments, and care.
Shifting our mindset, supporting healthcare connectivity, removing inequalities overall across Europe is our mission and even more now in a time of crisis, helping the Ukrainian people dealing with cancer is a good place to begin this transformative revolution.
1) Whether we have a chance to foster more holistic and integrated approaches to receive information and care, by supporting coordination and maximising an enabling and health-enhancing effect of care across services from different countries?
2) Whether actions should address the social determinants of health, the countries where they are now, the health need which they have, the social and language barriers are the conditions which have to be taken into consideration in a coordinated manner?
How might we improve patients and /or people who seek healthcare support, access to healthcare services at an EU & the Member States Healthcare systems level? Especially in a time of crisis in Europe.
How might we support refugees fleeing from their countries by navigating them to medical centres to receive best available care?
Precision medicine aims to personalise care for every individual. Nongenomic and genomic determinants, combined with information from patient symptoms, clinical history, and lifestyle (nutrition, physical activity, stress etc.), can facilitate personalised diagnosis and prognostics. Yet this goal requires access to massive amounts of data which may come from different structured and unstructured sources; these can be our medical records, laboratory testing, a range of medical devices as well as from the patient himself. AI & ML can combine input from these multiple sources, analyse them and identify biomarkers that can support health professionals make more informed decisions. The convergence of precision medicine with the advanced AI capabilities will improve the ability to personalise care – improve diagnosis, risk prediction as well as therapy planning.
HCPs want to better predict treatment response, given uncertainty around which treatment to prescribe to which patient and when to prescribe. How do we risk assess the patients, match them with the right treatment (personalised). How can we transform the wealth of data and link it to the predictive nature of how the patient will respond?
Being diagnosed with cancer is overwhelming and comes as a blow. Patients may feel on a roller coaster of emotions—they are scared, lost & confused not knowing what to expect, who to refer to, what to do and how to tell their loved ones. They directly refer to “Dr. Google” to look for information about their disease, possible treatments, QoL strategies with the aim to have better understanding of their disease and learn how to better cope with their disease & treatment, yet information is not always valid, accessible, nor personalised or tailored to the patient’s status and needs therefore left with huge amounts of non-relevant information. Coming to the doctor, the physician’s time is limited and mostly focusing on the physical aspects of the disease & treatment, not leaving much time to ask questions nor discuss more holistic aspects of the disease such as emotional, psychological, social aspects. The patient (& caregiver in many cases) leaves the room with unanswered questions, doesn’t remember much of what has been said, and feels he is not heard, nor seen as a whole.
The need for navigating this journey along the emotional psychological stress is overwhelming & patients and their caregivers look for support (case manager/companion/partner) to help manage their disease holistically – starting from having clarity around their disease and treatment by having access to reliable and personalised information during their journey as well as having an integrated holistic care system , supporting them and their loved ones to navigate through the different aspects of their disease – medical, emotional, logistical, psychological, social, rights.
How can we support patients to navigate through the complexity of their disease and treatment ensuring they have validated holistic information about their disease journey & treatment and be empowered to effectively manage their care
As medical events pivoted from conference centres and meeting rooms to the virtual settings, learning opportunities continue. Lectures and presentations are translated to the new digital world, yet the ability to connect and network is relatively lost. Peer interaction is essential not only for information exchange but to share practical insights, allows consultation & in-person experience cross country and across borders leading to better disease management.
This peer-based learning/ consultation is highly valued amongst practising clinicians and was generally achieved when HCPs and KOLs met their peers in national & Intl conferences, group debates, advisory boards and even during quick corridor conversations. Attempting to replicate these in-person experiences into the digital space creates challenges and are not effective nor impactful as face-to-face engagements.
How might we improve HCP medical exchange enabling physicians to easily communicate, consult, exchange opinions leveraging individual experts & centres of excellence knowledge, experiences, and practices?
How can we leverage the technological expertise to allow HCPs to connect with leading experts across countries to get advice / counselling for their cases?
Application for 2022Calling2Scale is closed.
Interested in participating in the next cohort?
Email [email protected]
